0001062993-22-004988.txt : 20220218 0001062993-22-004988.hdr.sgml : 20220218 20220218164540 ACCESSION NUMBER: 0001062993-22-004988 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220216 FILED AS OF DATE: 20220218 DATE AS OF CHANGE: 20220218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snow Ellen CENTRAL INDEX KEY: 0001786643 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39969 FILM NUMBER: 22653510 MAIL ADDRESS: STREET 1: C/O PEAR THERAPEUTICS, INC. STREET 2: 200 STATE STREET, 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pear Therapeutics, Inc. CENTRAL INDEX KEY: 0001835567 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 854103092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6469322774 MAIL ADDRESS: STREET 1: 200 STATE STREET STREET 2: 13TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Thimble Point Acquisition Corp. DATE OF NAME CHANGE: 20201208 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2022-02-16 0001835567 Pear Therapeutics, Inc. PEAR 0001786643 Snow Ellen C/O PEAR THERAPEUTICS, INC. 200 STATE STREET, 13TH FLOOR BOSTON MA 02109 0 1 0 0 Chief Accounting Officer Restricted Stock Units 2022-02-16 4 A 0 61576 0 A Common Stock 61576 61576 D Each restricted stock unit represents a contingent right to receive one share of PEAR common stock. The restricted stock units shall vest and settle as to 33% of the shares on January 14, 2023, 33% of the shares on January 14, 2024 and the final 34% on January 14, 2025. /s/ Stacie S. Aarestad, Attorney-in-Fact 2022-02-18